Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.
2.

Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Ronaldson PT, Davis TP.

Ther Deliv. 2011 Aug;2(8):1015-41. doi: 10.4155/tde.11.67. Review.

3.

Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.

Wilson B, Samanta MK, Santhi K, Kumar KP, Paramakrishnan N, Suresh B.

Brain Res. 2008 Mar 20;1200:159-68. doi: 10.1016/j.brainres.2008.01.039. Epub 2008 Jan 26.

PMID:
18291351
4.

Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.

Roher AE, Kokjohn TA.

Alzheimers Dement. 2009 Sep;5(5):437-8. doi: 10.1016/j.jalz.2009.07.037. No abstract available.

PMID:
19751925
5.

Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors.

Rice A, Michaelis ML, Georg G, Liu Y, Turunen B, Audus KL.

J Mol Neurosci. 2003;20(3):339-43.

PMID:
14501017
6.

Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: a physical and conceptual challenge.

Hachinski V, Lee TY.

Alzheimers Dement. 2009 Sep;5(5):435-6. doi: 10.1016/j.jalz.2009.07.002. No abstract available.

PMID:
19751924
7.

Delivery of therapeutic molecules into the CNS.

Emborg ME, Kordower JH.

Prog Brain Res. 2000;128:323-32. Review. No abstract available.

PMID:
11105691
8.

Morphine facilitates doxorubicin penetration in the central nervous system: a new prospect for therapy of brain tumors.

Sardi I.

J Neurooncol. 2011 Sep;104(2):619-20. doi: 10.1007/s11060-010-0518-9. Epub 2011 Jan 14. No abstract available.

PMID:
21234643
9.

The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier.

Barbu E, Molnàr E, Tsibouklis J, Górecki DC.

Expert Opin Drug Deliv. 2009 Jun;6(6):553-65. doi: 10.1517/17425240902939143 . Review.

PMID:
19435406
10.

[Role of the blood-brain barrier in Alzheimer's disease].

Gosselet F, Candela P, Cecchelli R, Fenart L.

Med Sci (Paris). 2011 Nov;27(11):987-92. doi: 10.1051/medsci/20112711015. Epub 2011 Nov 30. Review. French.

11.

[New methods of drug delivery through the blood brain barrier].

Bruhn C.

Dtsch Med Wochenschr. 2012 May;137(21):p18. doi: 10.1055/s-0032-1301818. Epub 2012 May 23. German. No abstract available.

PMID:
22622506
12.

Using blood brain barrier disruption by methamphetamine for drug delivery.

Kast RE.

J Neurooncol. 2007 Oct;85(1):109-10. Epub 2007 Apr 27. No abstract available.

PMID:
17464448
13.

Getting into the brain: approaches to enhance brain drug delivery.

Patel MM, Goyal BR, Bhadada SV, Bhatt JS, Amin AF.

CNS Drugs. 2009;23(1):35-58. doi: 10.2165/0023210-200923010-00003. Review.

PMID:
19062774
14.

Targeted drug delivery to the brain; (blood-brain barrier, efflux, endothelium, biological transport).

Terasaki T, Pardridge WM.

J Drug Target. 2000;8(6):353-5. No abstract available.

PMID:
11328661
15.

Blood-brain barrier transport of drugs for the treatment of brain diseases.

Gabathuler R.

CNS Neurol Disord Drug Targets. 2009 Jun;8(3):195-204. Review.

PMID:
19601817
16.

Altering the properties of the blood-brain barrier: disruption and permeabilization.

Fortin D.

Prog Drug Res. 2003;61:125-54. Review. No abstract available.

PMID:
14674611
17.

Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.

Gabathuler R.

Neurobiol Dis. 2010 Jan;37(1):48-57. doi: 10.1016/j.nbd.2009.07.028. Epub 2009 Aug 5. Review.

PMID:
19664710
18.

Vector-mediated drug delivery to the brain.

Temsamani J, Rousselle C, Rees AR, Scherrmann JM.

Expert Opin Biol Ther. 2001 Sep;1(5):773-82. Review.

PMID:
11728213
19.

Negative relationship between morphine analgesia and P-glycoprotein expression levels in the brain.

Hamabe W, Maeda T, Kiguchi N, Yamamoto C, Tokuyama S, Kishioka S.

J Pharmacol Sci. 2007 Dec;105(4):353-60. Epub 2007 Dec 8.

20.

Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology.

Tournier N, Declèves X, Saubaméa B, Scherrmann JM, Cisternino S.

Curr Pharm Des. 2011;17(26):2829-42. Review.

PMID:
21827411

Supplemental Content

Support Center